EPIPEN 300 microgram (µg) Adrenaline Injection Syringe Auto-Injector (AUST R 42978)
Published 22 March 2017
Product
The following batches of EpiPen® 300 microgram (µg) Adrenaline Injection Syringe Auto-Injectors (AUST R 42978) used for the treatment of allergic emergencies (anaphylaxis)): Batch number 5FA665 Expiry Apr 17 Batch number 5FA6651 Expiry Apr 17 Batch number 5FA6652 Expiry Apr 17 Batch number 5FA6653 Expiry Apr 17
Why it was recalled
There is a potential that these devices may contain a defective part that may result in the device failing to activate or requiring increased force to activate.
Hazard
The failure of the auto-injector to activate may result in patients not receiving the required dose of adrenaline, causing the worsening of symptoms of anaphylaxis or anaphylactic reactions, which could be life threatening.
Source: Based on ACCC data or other content. ACCC © Commonwealth of Australia. ACCC-owned material is licensed under CC BY 4.0. RecallMatch extracts and formats notice information for screening. Third-party material may have separate rights. Source and reuse terms. Verify details in the official notice. RecallMatch is independent of the ACCC.